Table 1 Preoperative characteristics in all patients, patients without PHF, with PHF, and with severe PHF
Variables | All patients (n = 382) | Without PHF (n = 347) | PHF (n = 35) | p valuea | Severe PHF (n = 7) | p valueb |
|---|---|---|---|---|---|---|
Age (years) | 69 [62–75] | 68 [62–75] | 73 [68–78] | 0.004 | 75 [72–78] | 0.035 |
Female gender | 19% (73) | 19% (66) | 20% (7) | 0.82 | 29% (2) | 0.62 |
BMI (kg/m2) | 27 [24–30] | 27 [24–29] | 28 [24–31] | 0.39 | 30 [23–31] | 0.78 |
EuroSCORE II | 2.4 [1.6–3.9] | 2.3 [1.6–3.8] | 3.8 [2.6–6.1] | < 0.0001 | 9.0 [4.2–11.1] | 0.001 |
Diabetes | 24% (91) | 23% (79) | 34% (12) | 0.15 | 57% (4) | 0.06 |
Hypertension | 61% (231) | 60% (207) | 69% (24) | 0.37 | 100% (7) | 0.046 |
COPD | 7% (26) | 6% (21) | 14% (5) | 0.08 | 14% (1) | 0.37 |
Hemoglobin (g/L) | 137 ± 14 | 137 ± 13 | 133 ± 14 | 0.11 | 121 ± 11 | 0.002 |
Troponin T (ng/L) | 0 [0–60] | 0 [0–50] | 30 [0–180] | 0.13 | 220 [30–450] | 0.019 |
p-Creatinine (μmol/L) | 91 [80–104] | 90 [79–104] | 96 [86–115] | 0.016 | 100 [95–147] | 0.09 |
eGFR (mL min−1 • 1.73 m−2) | 76 [58–97] | 77 [59–97] | 67 [47–84] | 0.023 | 56 [40–79] | 0.12 |
NT-proBNP (ng/L) | 420 [150–970] | 380 [140–864] | 900 [410–1730] | < 0.0001 | 1920 [1030–4202] | 0.001 |
Cerebrovascular disease | 8% (32) | 9% (30) | 6% (2) | 0.75 | 0 | 1 |
Three-vessel disease | 77% (293) | 75% (260) | 94% (33) | 0.01 | 100% (7) | 0.2 |
Left main stenosis | 36% (138) | 35% (121) | 48% (17) | 0.14 | 57% (4) | 0.25 |
AMI < 3 weeks | 65% (249) | 63% (220) | 83% (29) | 1 | 86% (6) | 0.43 |
History of AMI | 73% (278) | 71% (247) | 89% (31) | 0.028 | 86% (6) | 0.68 |
CCS IV | 60% (230) | 60% (207) | 66% (23) | 0.59 | 86% (6) | 0.25 |
Angina at rest < 48 h | 17% (61) | 16% (53) | 24 (8) | 0.33 | 43% (3) | 0.09 |
Moderate LV dysfunction | 12% (47) | 11% (39) | 23% (8) | 0.06 | 43% (3) | 0.039 |
Severe LV dysfunction | 4% (14) | 3% (9) | 14% (5) | 0.005 | 43% (3) | 0.001 |